John Maraganore co-founded Orbital Therapeutics and is a venture partner at Entrée Bio, principal and CEO of JMM Innovations and co-CEO of Corsera Health. Previously served as founding CEO of Alnylam Pharmaceuticals from 2002 to 2021 after senior roles at Millennium Pharmaceuticals and Biogen.
John Maraganore co-founded Orbital Therapeutics and is a venture partner at Entrée Bio, principal and CEO of JMM Innovations and co-CEO of Corsera Health. Previously served as founding CEO of Alnylam Pharmaceuticals from 2002 to 2021 after senior roles at Millennium Pharmaceuticals and Biogen.
Career
John Maraganore holds an MS and PhD, Biochemistry and Molecular Biology from University of Chicago.
CHCo-Chief Executive Officer at Corsera Health from 2025-09 to Present
RTExternal Director at Rapport Therapeutics from 2024-03 to Present
External Director at Takeda from 2022-06 to PresentKTExternal Director at Kymera Therapeutics from 2022-02 to Present
JIPrincipal and Chief Executive Officer at JMM Innovations from 2022-01 to Present
BTExternal Director at Beam Therapeutics from 2021-11 to Present
OTCo-founder at Orbital Therapeutics until PresentCo-founded Orbital Therapeutics.
Venture Partner, Entrée Bio at Entrée Capital until Present
Founding Chief Executive Officer at Alnylam Pharmaceuticals from 2002-12 to 2021